Navamedic ASA
F:N1A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Navamedic ASA
F:N1A
|
NO |
|
Emergent BioSolutions Inc
NYSE:EBS
|
US |
|
Franklin BSP Realty Trust Inc
F:6VH
|
US |
|
B
|
BOC Hong Kong Holdings Ltd
F:BOF
|
HK |
|
Indika Energy Tbk PT
F:I41
|
ID |
|
E
|
E&E Recycling Inc
TPEX:8440
|
TW |
|
M
|
Mitek Systems Inc
F:MKQ
|
US |
|
AVITA Medical Inc
NASDAQ:RCEL
|
US |
|
Cerillion PLC
LSE:CER
|
UK |
|
Hudson Pacific Properties Inc
F:HP91
|
US |
|
Synergie SE
F:YSY
|
FR |
|
Nedap NV
F:NE3
|
NL |
|
ITAB Shop Concept AB
F:29I0
|
SE |
|
M
|
Mari Energies Ltd
KAR:MARI
|
PK |
Wall St Price Targets
N1A Price Targets Summary
Navamedic ASA
According to Wall Street analysts, the average 1-year price target for N1A is 2.79 EUR with a low forecast of 2.47 EUR and a high forecast of 3.18 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is N1A's stock price target?
Price Target
2.79
EUR
According to Wall Street analysts, the average 1-year price target for N1A is 2.79 EUR with a low forecast of 2.47 EUR and a high forecast of 3.18 EUR.
What is the Revenue forecast for Navamedic ASA?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 7%.
What is the Gross Profit forecast for Navamedic ASA?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 1 year is -2%.
What is the Operating Income forecast for Navamedic ASA?
Projected CAGR
30%
The compound annual growth rate for Operating Income over the next 8 years is 30%.
